Statin-Based Drug Lowers Bad Cholesterol
An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries and chest pain.
Over 29 million people in the United States have been prescribed Lipitor, manufactured by Pfizer. It is one of the most widely studied medicines in the world — with more than 17 years of research, and over 400 ongoing or completed clinical studies encompassing over 80,000 patients.
In clinical studies, Lipitor lowered bad cholesterol significantly more than generic Zocor (simvastatin). Lipitor is a statin that lower cholesterol in your body by blocking an enzyme in the liver. Bodies uses this enzyme to make cholesterol. When less cholesterol is made, the liver uses more of it from the blood, which results in lower levels of cholesterol in the blood.
Along with diet and exercise, Lipitor is proven to:
• Lower LDL ("bad" cholesterol) by 39 to 60 percent
• Lower triglycerides (a type of fat found in the blood) by 19 to 37 percent
• Raise HDL ("good" cholesterol) by 5 percent to 9 percent
More like this
- FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
- New FDA Indications Widen Lipitor’s Use into Heart Failure Prevention
- FDA Widens Lipitor Approval to Include Heart Disease Patients
- ACC: FDA Widens Lipitor Approval to Include Heart Disease Patients
- Plavix, Clopidogrel and Atorvastatin Cardiac Drugs Among Leaders in U.S. Drug Sales